• 272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16-18 June 2023, Hoofddorp, The Netherlands
• A case of acute hypercapnic respiratory failure secondary to late onset nemaline rod myopathy: A multi-disciplinary approach
• A longitudinal study using B mode ultrasound and power Doppler as monitoring imaging tools in inclusion body myositis
• A Practical Guide to Identify Patients With Multifocal Motor Neuropathy, a Treatable Immune-Mediated Neuropathy
• Adolescent-onset multisystem proteinopathy due to a novel VCP variant
• An Unusual Disease With a Common Presentation: Cricopharyngeal Dysfunction in Inclusion Body Myositis
• Anesthesia Spearheading Perioperative Safety Efforts in a Patient with Inclusion Body Myositis: A Case Report
• Anti-HMGCR (Hydroxy-3-Methylglutaryl-CoA Reductase) Myopathy: A Rare Cause of Proximal Muscle Weakness
• Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New Zealand
• Anti-Ku + myositis: an acquired inflammatory protein-aggregate myopathy
• Asia-Inclusive Global Development of Enpatoran: Results of an Ethno-Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial
• Assessing PET/CT's diagnostic accuracy in idiopathic myopathies
• Association between ZASP/LDB3 Pro26Ser and Inclusion Body Myopathy
• Autoantibody evaluation in idiopathic inflammatory myopathies
• Autoimmune Myopathies
• Beevor's sign in a case of inclusion body myositis
• Bilateral Facial Palsy: A Rare Presenting Symptom for Inclusion Body Myositis
• Bone scan findings of Paget's disease of bone in patients with VCP Multisystem Proteinopathy 1
• Cancer risk and mortality in hospitalised patients with idiopathic inflammatory myopathies in Western Australia
• Cancer Risk and Mortality in Hospitalized Patients With Idiopathic Inflammatory Myopathies in Western Australia
• Cell type mapping of inflammatory muscle diseases highlights selective myofiber vulnerability in inclusion body myositis
• Cellular activation patterns of CD10+ fibro-adipogenic progenitors across acquired disease states in human skeletal muscle biopsies
• Comparison of Muscle Biopsy Features with Myositis Autoantibodies in Inflammatory Myopathies: A Pilot Experience
• Compound muscle action potential of whole-forearm flexors: A clinical biomarker for inclusion body myositis
• Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group
• Contribution of Complement, Microangiopathy and Inflammation in Idiopathic Inflammatory Myopathies
• Correction: Testosterone treatment combined with exercise to improve muscle strength, physical function and quality of life in men affected by inclusion body myositis: A randomised, double-blind, placebo-controlled, crossover trial
• Cost of illness in inclusion body myositis: results from a cross-sectional study in Germany
• Cross-sectional study of patients with VCP multisystem proteinopathy 1 using dual-energy x-ray absorptiometry
• Diagnosing and characterizing inflammatory myopathies at an Australian tertiary public hospital: Resource utilization and direct healthcare costs
• Differentiating idiopathic inflammatory myopathies by automated morphometric analysis of MHC-1, MHC-2 and ICAM-1 in muscle tissue
• Distinct Transcript-Level Expression Profiles and Unique Alternative Splicing in Inflammatory Myopathies
• Does inspiratory muscle training improve lung function and quality of life in people with inclusion body myositis? A pilot study
• Effect of sirolimus on muscle in inclusion body myositis observed with magnetic resonance imaging and spectroscopy
• Effects of sporadic inclusion body myositis on skeletal muscle fibre type specific morphology and markers of regeneration and inflammation
• Efficacy of endoscopic cricopharyngeal myotomy using a curved rigid laryngoscope in patients with sporadic inclusion body myositis: four retrospective case reviews
• Electromyography varies by stage in inclusion body myositis
• Evaluating disease status in idiopathic inflammatory myopathies with quantitative muscle ultrasound
• Evaluation of Neuromuscular Diseases and Complaints by Quantitative Muscle MRI
• Frequency of EMG abnormalities in idiopathic inflammatory myopathies under the EULAR/ACR classification criteria
• From data to diagnosis: how machine learning is revolutionizing biomarker discovery in idiopathic inflammatory myopathies
• Granulomatous myositis: characteristics and outcome from a monocentric retrospective cohort study
• High-resolution HLA genotyping in inclusion body myositis refines 8.1 ancestral haplotype association to DRB1*03:01:01 and highlights pathogenic role of arginine-74 of DRbeta1 chain
• High-resolution HLA genotyping in inclusion body myositis refines 8.1 ancestral haplotype association to DRB1*03:01:01 and highlights pathogenic role of arginine-74 of DRβ1 chain
• HIV-associated nemaline myopathy manifesting as bent spine syndrome
• Identification of distinct immune signatures in inclusion body myositis by peripheral blood immunophenotyping using machine learning models
• Idiopathic Inflammatory Myopathies
• Imaging swallowing function and the mechanisms driving dysphagia in inclusion body myositis
• Immunohistochemical expression in idiopathic inflammatory myopathies at a single center in Vietnam
• Impact of sex, age at onset, and anti-cN1A antibodies on sporadic inclusion body myositis
• Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey
• Inclusion Body Myositis
• Inclusion body myositis
• Inclusion body myositis-health-related quality of life and care situation during phases of the "patience journey" in Germany: results from a qualitative study
• Inclusion body myositis, viral infections, and TDP-43: a narrative review
• Inclusion body myositis: small steps towards future advances
• Inclusion-body myositis associated with Sjogren's disease: clinical characteristics and comparison with other Sjogren-associated myositis
• Interpreting a Delayed Workup of Idiopathic Inflammatory Myopathy
• Intravenous immunoglobulin in the treatment of sporadic inclusion body myositis: time for new evidence?
• Key target genes related to anti-breast cancer activity of ATRA: A network pharmacology, molecular docking and experimental investigation
• Late-onset myopathies
• Measurement properties of the Inclusion Body Myositis Functional Rating Scale
• Mitochondrial defects in sporadic inclusion body myositis-causes and consequences
• Mitochondrial transfer and implications for muscle function in idiopathic inflammatory myopathies
• msp1, msp2, and glurp genotyping to differentiate Plasmodium falciparum recrudescence from reinfections during prevention of reestablishment phase, Sri Lanka, 2014-2019
• Myosite à inclusions
• Myositis-associated antibodies predict the severity of lung involvement in adult patients with inflammatory myositis - a cohort study of 70 adult patients with myositis in a single center
• NLRP3 inflammasome activation and altered mitophagy are key pathways in inclusion body myositis
• Paraneoplastic dermatomyositis associated with urothelial cancer: report of a case and systematic review of the literature
• Paraneoplastic myopathies
• Participant experiences of guided self-help Acceptance and Commitment Therapy for improving quality of life in muscle disease: a nested qualitative study within the ACTMus randomized controlled trial
• Patient experiences of muscle biopsy in idiopathic inflammatory myopathies: a cross-sectional survey
• Phenotypic spectrum of inclusion body myositis
• Polymyositis is a rare and favourable outcome subtype of idiopathic inflammatory myopathy in Chinese patients
• Quantitative muscle MRI in sporadic inclusion body myositis (sIBM): A prospective cohort study
• Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum
• Quantum simulation of Pauli channels and dynamical maps: Algorithm and implementation
• Relationship Between Hand Function and Handheld Ultrasound Imaging in Inclusion Body Myositis
• Retrospective Study Shows That Serum Levels of Chemokine CXCL10 and Cytokine GDF15 Support a Diagnosis of Sporadic Inclusion Body Myositis and Immune-Mediated Necrotizing Myopathy
• Revealing myopathy spectrum: integrating transcriptional and clinical features of human skeletal muscles with varying health conditions
• Safety and efficacy of blood flow restriction exercise in individuals with neurological disorders: A systematic review
• Sarcoid myopathy: an insidious diagnosis that can mimic inclusion body myositis
• Sarcoplasmic Myxovirus Resistance Protein A: A Study of Expression in Idiopathic Inflammatory Myopathy
• Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis
• Sporadic Inclusion Body Myositis
• Sporadic inclusion body myositis (sIBM) in a patient with a history of diffuse large B-cell lymphoma
• Sporadic Inclusion Body Myositis at the Crossroads between Muscle Degeneration, Inflammation, and Aging
• Sporadic inclusion body myositis-derived myotube culture revealed muscle cell-autonomous expression profiles
• Systemic sclerosis associated myopathy: how to treat
• Tendon Transfers to Improve Grip and Pinch in Patients with Sporadic Inclusion Body Myositis
• The prevalence, epidemiological characteristics and mortality trends of inflammatory myopathies patients in Oman: the Prevision study
• The spectrum of idiopathic inflammatory myopathies in Western Australia: epidemiological characteristics and mortality over time
• Title: Sarcopenia assessed by DXA and hand-grip dynamometer: a potential marker of damage, disability and myokines imbalance in inflammatory myopathies
• Treatment resistance in inclusion body myositis: the role of mast cells
• Two cases of inclusion body myositis presenting with unusual symptoms,head drop and facial diplegia and different responses to intravenous immunoglobulin treatment
• Valosin-Containing Protein (VCP)/p97 Oligomerization
• VCP activator reverses nuclear proteostasis defects and enhances TDP-43 aggregate clearance in multisystem proteinopathy models
• Watch for inclusion body myositis
• What is in the Myopathy Literature?
• Whole-body muscle magnetic resonance imaging in inflammatory myopathy with mitochondrial pathology